Literature DB >> 24899036

Evaluation of a new protocol for retrospective diagnosis of congenital toxoplasmosis by use of Guthrie cards.

Antonella Marangoni1, Maria Grazia Capretti2, Morena De Angelis2, Paola Nardini3, Monica Compri3, Claudio Foschi3, Azzurra Orlandi2, Concetta Marsico2, Francesca Righetti4, Giacomo Faldella2, Roberto Cevenini3.   

Abstract

The aim of this study was to assess the diagnostic value of IgM Western blotting (WB), IgA enzyme immunoassay (EIA), and DNA amplification by real-time PCR on Guthrie cards to retrospectively establish the diagnosis of congenital toxoplasmosis (CT). To this purpose, Guthrie cards were collected from 18 infants born to mothers with primary Toxoplasma gondii infection during pregnancy. Moreover, the analytical sensitivity of T. gondii PCR was assessed by testing mock dried blood specimens set up with several known DNA dilutions. IgM WB was demonstrated to be the most sensitive method. When the results of T. gondii DNA detection and specific IgM recovery were combined, retrospective CT diagnosis by using Guthrie cards was established in 3 out of 6 infected infants (sensitivity, 50%; 95% confidence interval, 26.8% to 73.2%). No positive PCR or serologic results were found in the group of 12 uninfected infants, demonstrating the excellent specificity of the three methods (95% confidence interval, 78.1% to 99.5%). The findings of the present study suggest that, in cases of missed diagnosis of CT at birth, analysis of Guthrie cards for children with compatible clinical findings after the perinatal period, in particular the combination of recovery of specific IgM antibodies and T. gondii DNA amplification, could be helpful. Nevertheless, since suboptimal conditions of storage of dried blood specimens can seriously affect sensitivity, negative results cannot rule out CT diagnosis. In contrast, because of the excellent specificity shown by IgM serologic testing and T. gondii DNA amplification on Guthrie cards, positive results obtained by either of the two methods should be considered diagnostic.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899036      PMCID: PMC4136192          DOI: 10.1128/JCM.00106-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.

Authors:  Tudor Rares Olariu; Jack S Remington; Rima McLeod; Ambereen Alam; Jose G Montoya
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots.

Authors:  M Paul; E Petersen; Z S Pawlowski; J Szczapa
Journal:  Pediatr Infect Dis J       Date:  2000-01       Impact factor: 2.129

3.  Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.

Authors:  M H Bessières; A Berrebi; M Rolland; M C Bloom; C Roques; S Cassaing; C Courjault; J P Séguéla
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-01       Impact factor: 2.435

4.  Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.

Authors:  Russell D Bradford; Gretchen Cloud; Alfred D Lakeman; Suresh Boppana; David W Kimberlin; Richard Jacobs; Gail Demmler; Pablo Sanchez; William Britt; Seng-jaw Soong; Richard J Whitley
Journal:  J Infect Dis       Date:  2004-12-16       Impact factor: 5.226

5.  Delayed maturation of IgG avidity in congenital toxoplasmosis.

Authors:  W Buffolano; M Lappalainen; L Hedman; F Ciccimarra; M Del Pezzo; R Rescaldani; N Gargano; K Hedman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-19       Impact factor: 3.267

6.  Evaluation of DNA extraction methods for dried blood spots in the diagnosis of congenital cytomegalovirus infection.

Authors:  Jutte J C de Vries; Eric C J Claas; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Virol       Date:  2009-09-24       Impact factor: 3.168

Review 7.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

8.  Real-time PCR as a prognostic tool for human congenital toxoplasmosis.

Authors:  Júlia Gatti Ladeia Costa; Ana Carolina Aguiar Vasconcelos Carneiro; Alice Thomáz Tavares; Gláucia Manzan Queiroz Andrade; Daniel Vitor Vasconcelos-Santos; José Nélio Januário; Daniel Menezes-Souza; Ricardo Toshio Fujiwara; Ricardo Wagner Almeida Vitor
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

9.  Cytomegalovirus antibodies in dried blood spots: a minimally invasive method for assessing stress, immune function, and aging.

Authors:  Jennifer B Dowd; Allison E Aiello; Laura Chyu; Yuan-Yen Huang; Thomas W McDade
Journal:  Immun Ageing       Date:  2011-01-13       Impact factor: 6.400

10.  Newborn screening for congenital infectious diseases.

Authors:  Eurico Camargo Neto; Rosélia Rubin; Jacqueline Schulte; Roberto Giugliani
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  3 in total

1.  Validation of dried blood spots in monitoring toxoplasmosis.

Authors:  Mamdouh M Hegazy; Mona K Hegazy; Manar S Azab; Nairmen Nabih
Journal:  Pathog Glob Health       Date:  2020-05-18       Impact factor: 2.894

2.  Contribution of a Comparative Western Blot Method to Early Postnatal Diagnosis of Congenital Syphilis.

Authors:  Antonella Marangoni; Claudio Foschi; Maria Grazia Capretti; Paola Nardini; Monica Compri; Luigi Tommaso Corvaglia; Giacomo Faldella; Roberto Cevenini
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

Review 3.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.